U.S. flag

An official website of the United States government

NM_000539.3(RHO):c.50C>T (p.Thr17Met) AND not specified

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 27, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001002098.10

Allele description [Variation Report for NM_000539.3(RHO):c.50C>T (p.Thr17Met)]

NM_000539.3(RHO):c.50C>T (p.Thr17Met)

Gene:
RHO:rhodopsin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q22.1
Genomic location:
Preferred name:
NM_000539.3(RHO):c.50C>T (p.Thr17Met)
HGVS:
  • NC_000003.12:g.129528783C>T
  • NG_009115.1:g.5145C>T
  • NM_000539.3:c.50C>TMANE SELECT
  • NP_000530.1:p.Thr17Met
  • NC_000003.11:g.129247626C>T
  • P08100:p.Thr17Met
Protein change:
T17M; THR17MET
Links:
UniProtKB: P08100#VAR_004767; OMIM: 180380.0006; dbSNP: rs104893769
NCBI 1000 Genomes Browser:
rs104893769
Molecular consequence:
  • NM_000539.3:c.50C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001159945ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process)
Pathogenic
(Sep 27, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV001159945.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The RHO c.50C>T; p.Thr17Met variant (rs104893769) is reported in the medical literature as segregating with disease in families with retinitis pigemtosa (Jacobson 2016, Sheffield 1991, Sung 1991). Additionally, functional studies of this variant in cell culture and in a mouse model show the rhodopsin protein is deficient (Krebs 2010, Li 1998). This variant is reported in the ClinVar database (Variation ID: 13018) and in the Genome Aggregation Database in 1 out of 30948 alleles, indicating it is not a common polymorphism. The threonine at codon 17 is highly conserved and computational algorithms (PolyPhen-2, SIFT) predict this variant is deleterious. Additionally, other variants in this region are considered pathogenic (see link to RHO variants in ClinVar below). Considering available information, this variant is classified as pathogenic. Pathogenic RHO variants are causative for autosomal dominant or recessive retinitis pigmentosa (MIM: 613731) or retinitis punctata albescens (MIM: 136880). However, this variant is specifically associated with autosomal dominant retinitis pigmentosa. References: Link to RHO variants in ClinVar: http://www.ncbi.nlm.nih.gov/clinvar/?term=RHO%5Bgene%5D Jacobson SG et al. Complexity of the Class B Phenotype in Autosomal Dominant Retinitis Pigmentosa Due to Rhodopsin Mutations. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4847-4858. Krebs MP et al. Molecular mechanisms of rhodopsin retinitis pigmentosa and the efficacy of pharmacological rescue. J Mol Biol. 2010 Feb 5;395(5):1063-78. Li T et al. Effect of vitamin A supplementation on rhodopsin mutants threonine-17 --> methionine and proline-347 --> serine in transgenic mice and in cell cultures. Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11933-8. Sheffield VC et al. Identification of novel rhodopsin mutations associated with retinitis pigmentosa by GC-clamped denaturing gradient gel electrophoresis. Am J Hum Genet. 1991 Oct;49(4):699-706. Sung CH et al. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6481-5.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 30, 2024